Mid-Afternoon Market Update: Dow climbs 400 points; nCino shares jump
|Toward the end of trading Tuesday, the Dow traded up 1.59% to 26,500.62 while the NASDAQ rose 0.27% to 10,419.38. The S&P also rose, gaining 0.74% to 3,178.67.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 3,364,547 cases with around 135,615 deaths. Brazil confirmed a total of over 1,884,967 COVID-19 cases with 72,833 deaths, while India reported a total of at least 906,752 confirmed cases and 23,727 deaths. In total, there were at least 13,113,181 cases of COVID-19 worldwide with over 573,288 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Energy shares rose 2.7% on Tuesday. Meanwhile, top gainers in the sector included Nabors Industries Ltd. NBR 13.2%, up 11%, and Matador Resources Company MTDR 8.18%, up 9%.
In trading on Tuesday, financial shares rose by just 0.04%.
Top Headline
JPMorgan Chase & Co. JPM 0.33% reported better-than-expected results for its second quarter.
JPMorgan reported quarterly earnings of $1.38 per share, beating analysts’ estimates of $1.04 per share. The company reported sales of $33.00 billion, exceeding expectations of $30.29 billion.
Equities Trading UP
INmune Bio, Inc. INMB 134.46% shares shot up 96% to $17.35 following a positive clinical readout from the company. The company released interim results from a Phase 1b study of its lead drug candidate XPro 1595 in Alzheimer's disease, showing the investigational drug reduced neuroinflammation by 40.6% in a brain fiber pathway, which is important for learning and memory.
Shares of Rigel Pharmaceuticals, Inc RIGL 103.55% got a boost, shooting 109% to $4.51 after the company announced the launch of an investigator-sponsored trial of Fostamatinib for the treatment of COVID-19 pneumonia.
nCino, Inc. NASDAQNCNO shares were also up, gaining 163% to $81.44 after the company priced its IPO at $31 per share.
Equities Trading DOWN
Equillium, Inc. EQ 43.36% shares tumbled 41% to $15.62 after the company filed a prospectus supplement related to a common stock offering of up to $150 million. Equillium shares jumped more than 730% on Monday after the company announced its clinical trial showed Itolizumab reduced mortality in patients hospitalized with COVID-19.
Shares of WiMi Hologram Cloud Inc. WIMI 27.24% were down 26% to $18.24. WiMi Hologram Cloud shares jumped 69% on Monday on continued momentum after the company announced its AR+AI Vision will drive a new wave of 5G applications.
Osmotica Pharmaceuticals plc OSMT 20.6% was down, falling 21% to $6.11 after the company announced a public offering of 5 million shares at $6.55 per share.
Commodities
In commodity news, oil traded up 0.4% to $40.26, while gold traded down 0.1% to $1,814.00.
Silver traded down 1.1% Tuesday to $19.57, while copper fell 0.7% to $2.934.
Euro zone
European shares closed mostly lower today. The eurozone’s STOXX 600 fell 0.84%, the Spanish Ibex Index fell 1.01%, while Italy’s FTSE MIB Index declined 0.62%. Meanwhile, the German DAX 30 dropped 0.80%, French CAC 40 declined 0.96% and UK shares rose 0.06%.
Economics
The NFIB small business optimism index rose to 100.6 in June, a 6.2 points rise from May's reading.
US inflation rate rose to 0.6% in June versus May's 0.1%.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.